Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "Commonalities"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
product_txtF_mv:"National Center for Biotechnology Information"
Showing
161
-
180
of
790
Search:
'"Commonalities"'
,
query time: 0.01s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
161
Pharmacoeconomic review report: Insulin degludec (Tresiba) (Novo Nordisk Canada Inc.)
Published 2017
CADTH
“
...CADTH
common
drug review...
”
Read Now
162
Pharmacoeconomic review report: Naltrexone hydrochloride and bupropion hydrochloride (Contrave) : (Bausch Health, Canada iInc.) :indication: an adjunct to a reduced-calorie diet an...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug review...
”
Read Now
163
Clinical review report: Ixekizumab (Taltz) (Eli Lilly Canada Inc.)
Published 2018
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug review...
”
Read Now
164
Clinical review report: Bictegravir/Emtricitabine/Tenofovir alafenamide (B/FTC/TAF) (Biktarvy) (Gilead Sciences Canada, Inc.) : indication : a complete regimen for the treatment of...
Published 2018
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug review...
”
Read Now
165
CADTH Canadian Drug Expert Committee recommendation: Nitisinone (nitisinone tablets -- Cycle Pharmaceuticals Ltd.) : indication : the treatment of adult and pediatric patients with...
Published 2018
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug review...
”
Read Now
166
Clinical review report: Budesonide (Jorveza) (AVIR Pharma Inc.) : indication : for the induction of clinicopathologic remission in adults with eosinophilic esophagitis
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug review...
”
Read Now
167
CADTH Canadian Drug Expert Committee Recommendation: Halobetasol propionate and tazarotene (Duobrii -- Bausch Health, Canada Inc.) : indication : psoriasis, moderate to severe plaq...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug review...
”
Read Now
168
Pharmacoeconomic review report: Ertugliflozin (Steglatro) (Merck Canada Inc.) : indication : type 2 diabetes mellitus
Published 2019
CADTH
“
...CADTH
common
drug review...
”
Read Now
169
Pharmacoeconomic review report: Nitisinone (Orfadin) (Sobi Canada Inc.)
Published 2018
CADTH
“
...CADTH
common
drug review...
”
Read Now
170
Clinical review report: Dolutegravir (Tivicay)
Published 2014
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug review...
”
Read Now
171
Ocrelizumab (Ocrevus) (Hoffmann-La roche limited)
Published 2018
CADTH
“
...CADTH
common
drug review...
”
Read Now
172
Clinical review report: Netupitant/palonosetron 300 mg/0.5 mg (Akynzeo) (Purdue Pharma)
Published 2018
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug review...
”
Read Now
173
Clinical review report: Ustekinumab (Stelara/Stelara I.V.) Janssen Inc. : indication: treatment of adult patients with moderately to severely active ulcerative colitis who have had...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug review...
”
Read Now
174
Pharmacoeconomic review report: Letermovir (Prevymis) (Merck Canada Inc.)
Published 2018
CADTH
“
...CADTH
common
drug review...
”
Read Now
175
Pharmacoeconomic review report: Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi) (Gilead Sciences Canada, Inc.)
Published 2018
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug review...
”
Read Now
176
Pharmacoeconomic review report: Obeticholic acid (Ocaliva) : (Intercept Pharma Canada, Inc.) : indication : for the treatment of primary biliary cholangitis
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug review...
”
Read Now
177
CADTH Canadian Drug Expert Committee recommendation: Guselkumab (Tremfya -- Janssen Inc.) : indication : for the treatment of adult patients with moderate-to-severe plaque psoriasi...
Published 2018
CADTH
“
...CADTH
common
drug review...
”
Read Now
178
Subsequent entry biologic review report: Inflectra (Infliximab)
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug review...
”
Read Now
179
CADTH Canadian Drug Expert Committee final recommendation: Mifepristone and misoprostol (Mifegymiso -- Celopharma Inc.) : indication: medical termination of pregnancy
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug review...
”
Read Now
180
CADTH Canadian Drug Expert Committee recommendation: Tocilizumab (Actemra - Hoffmann-La Roche Limited) : indication : giant cell arteritis
Published 2018
CADTH
“
...CADTH
common
drug review...
”
4
5
6
7
8
9
10
11
12
13
14
Back
Narrow Search
Remove Filters
Clear Filter
Collection: National Center for Biotechnology Information
Year of Publication
From:
To:
Classification
610 - Medicine & health
581
330 - Economics
256
140 - Specific philosophical schools
83
700 - The arts; fine & decorative arts
76
580 - Plants (Botany)
11
380 - Commerce, communications & transportation
7
more ...
615 - Pharmacology & therapeutics
4
see all ...
less ...
Language
English
790
Collection
National Center for Biotechnology Information
Author
Canadian Agency for Drugs and Technologies in Health
729
CADTH Canadian Drug Expert Committee
210
Canadian Diabetes Association
4
Kidney Foundation of Canada
2
Multiple Sclerosis Society of Canada
2
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?page=9&filter%5B%5D=product_txtF_mv%3A%22National+Center+for+Biotechnology+Information%22&lookfor=%22Commonalities%22&type=Series
Send by Email
×
Loading...